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ABSTRACT 
Oocyte quality is one of the main factors for the success of in vitro fertilization protocols. 
Apoptosis is known to affect oocyte quality and may impair subsequent embryonic development and 
implantation. The aim of this study was to investigate the apoptosis rate of single and pooled 
cumulus cells of cumulus cell–oocyte complexes (COCs), as markers of oocyte quality, prior to 
intracytoplasmatic sperm injection (ICSI).We investigated the apoptosis rate by TUNEL assay 
(DNA fragmentation) and caspase-3 immunoassay of single and pooled cumulus cells of COCs. 
The results showed that DNA fragmentation in cumulus cells was remarkably lower in patients who 
achieved a pregnancy than in those who did not. Cumulus cell apoptosis rate could be a marker for 
the selection of the best oocytes to be fertilized by intracytoplasmatic sperm injection.   
© 2015 Pak Publishing Group. All Rights Reserved. 
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Contribution/ Originality 
This study is one of very few studies which have investigated the apoptosis rate by TUNEL 
assay and caspase-3 immunoassay of single and pooled human cumulus cells of COCs. The 
apoptosis rate could be a marker for the selection of the best oocytes to be fertilized by 
intracytoplasmatic sperm injection. 
 
1. INTRODUCTION 
Several studies have been devoted to define criteria for predicting oocyte quality [1, 2] and 
selecting the most suitable oocytes for in vitro fertilization (IVF) cycles. Oocyte quality, as an 
expression of nuclear and cytoplasmic competence, is closely related to successful fertilization and 
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implantation. Oocyte quality, nuclear maturation, fertilization and implantation can be affected by 
different factors, such as ovarian hyperstimulation, patient age, the so-called ‘poor responder’ 
condition and endometriosis [3, 4].  
Most embryologists select oocytes on the basis of cumulus cell–oocyte complex (COC) 
morphology and oocyte features. It is currently understood that pregnancy and implantation rates 
are closely associated to the number of metaphase II (MII) oocytes retrieved [5]; however introduce 
of new criteria for oocyte selection could guarantee good rates of fertilization, pregnancy and 
implantation. 
Many researchers have investigated the relationship between oocytes and their surrounding 
somatic cells [6, 7]. Cumulus cells form a multilayer mass around oocytes during the maturation 
process, consequently protecting them and providing several molecules to the oocytes, through the 
gap junctions [8]. In an earlier paper, we demonstrated that a reduced rate of cumulus cell apoptosis 
improves rates of pregnancy and implantation [9], as a result of better oocyte quality [10]. It is 
possible that through gap junctions or other molecular pathways, the direct activation of the 
apoptotic process from cumulus cells moves to the oocytes, affecting the quality and developmental 
and implantation potential of the embryos [11, 12].  
The aim of the present study is to verify our hypothesis that the apoptosis rate of the cumulus 
cells of individual COCs can be used as a marker for selecting the best oocytes to be fertilized by 
intracytoplasmatic sperm injection (ICSI), through investigating the specific clinical outcomes of 
pregnancy rate.  
Usually, in a spontaneous menstrual cycle, one or two follicles are selected from a pool of 
follicles. The dominant follicle induces atresia on the other follicles through apoptotic pathway, 
operating a selection that assures a pregnancy rate that in general population is about 40%. To treat 
infertility, the patient included in an assisted reproductive technology (ART) program, receives an 
hormonal stimulation to produce more than 1 or 2 spontaneous follicles. Usually more than 6 
follicles are produced by the ovaries including follicles than, in a natural cycle, should be 
eliminated by atresia. To date, it is unknown if the quality of the oocytes collected after hormonal 
stimulation, that escape from atretic selection, is comparable with  the dominant oocytes selected in 
a natural cycle.   
Apoptosis is the molecular pathway of atresia. For this reason it was decided to use DNA 
fragmentation, that is the molecular aspect of final steps of apoptotic process, as the molecular 
marker of oocyte quality. It was hypothesized that CoCs with a lower number of apoptotic cells 
could represent a model in which the surviving pathways prevail. This is a condition that allows to 
the oocyte to complete the maturation process, prior to ovulation, consisting in the synchronization 
of nuclear and cytoplasmic maturation, that seems to represent the basis of oocyte competence [12]. 
It is known that cumulus cells supply the oocytes, particularly during oogenesis, with nutrients that 
maintain meiotic arrest and participate in the induction of meiosis by driving the luteinizing 
hormone (LH) signal to the oocytes [13]. 
This study was approved by the Institutional Review Board of the Clinic. The patients 
involved in the study underwent ICSI for a severe male factor infertility (< 1 million/ml motile 
sperm) and provided written informed consent. 
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The study consisted of two different trials. The policy of the clinic was to fertilize a maximum 
of 3 oocytes for each patient included in the study. In the first trial, three oocytes, out of the total 
number of oocyte collected after hormonal stimulation, were selected for fertilization. We 
investigated the apoptosis rate of individual cumulus cells derived from each of the three oocytes 
selected to be fertilized by ICSI. The three COCs were previously selected, from the total of the 
oocytes collected,  using the morphological criteria by Veeck [1]. In the second trial, for each 
patient included in the study,  the apoptosis rate of the pooled cumulus cells derived from the 
selected 3 COCs were compared with the apoptosis rate of the pooled cumulus cells of non selected 
and not fertilized (supernumerary MII oocytes) (when more of five COCs at least were aspirated 
after pick-up). The aim of this second trial was to verify if the morphological selection by Veeck 
[1] was effective in selecting the best oocytes, according to the evaluation using molecular markers, 
comparing oocytes collected in the same patient, in the same cycle and after the same hormonal 
stimulation. 
 Twenty-two consecutive couples undergoing cycles of ICSI were included in the first trial, 
and 20 couples in the second trial, thus providing a total of 42 couples. The mean age of patients 
and COCs collected are described in Table 1.  
Investigations concerning the extent of DNA fragmentation were performed using the TUNEL 
assay (terminal deoxynucleotidyl transferase [TdT]). The aim of this assay is to recognize the 
terminal 3'OH ends of DNA by adding modified nucleotides (for this purpose was used the 
exogenous enzyme Terminal transferase (TdT). 
Moreover, to validate whether DNA fragmentation was related to the apoptotic process we 
performed in the same cells cleaved-caspase-3 immunoassay, one of the most important effector 
molecules of apoptosis.  
 
2. RESULTS 
The study was performed using cumulus cells isolated from single or pooled COCs collected 
from women undergoing cycles of ICSI. 
 
2.1. First Trial 
No differences in the mean of female and male ages, in the total number of COCs collected 
and selected, was found between the 2 trials as reported in Table 1.  
In the first trial, a total of 154 COCs were recovered, from which 58 MII oocytes were selected 
for ICSI treatment. Out of the 22 patients involved in this trial, 8 were pregnant (36% A Group) 
and 14 were not (63% B Group). Clinical outcomes are reported in Table 2. Twenty-four oocytes 
from A Group (n = 8), and 34 oocytes from B Group (n = 14) from the first trial were microinjected 
with sperm. No statistical difference was observed in fertilization rates (95.8% [A Group] vs 85.2% 
[B Group]) or morphological quality of the transferred embryos (expressed as grade A and B using 
Bolton’s definition) [14].   
The mean incidence of DNA fragmentation of cumulus cells from individual oocytes selected 
for ICSI treatment, evaluated by TUNEL assay, was lower in A Group than B Group (mean 6,7% 
[range 2,.2-13.3%] vs 13.2% [range 6.2-34.9%]; P< 0.05) (Figure 1, a,). Similarly, the results 
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obtained with immunoassay anti-cleaved caspase-3 showed that there was lower caspase-3 activity 
in cumulus cells from women who were pregnant than in those who did not were pregnant (mean 
5.2% [range: 1.2–8.6%] vs 11.8% [range: 5.6–14.8%]; P < 0.05) (Figure 1, b,). The percentage of 
cumulus cells undergoing apoptosis (as analysed by TUNEL assay and caspase-3 immunoassay) is 
shown in Table 3. It is noteworthy that most women who became pregnant had a DNA 
fragmentation rate (TUNEL) of less than 10% and a caspase-3 activity rate less than 7% in cumulus 
cells from at least one COC. 
 
2.2. Second Trial 
In the second trial, as shown in Table 4, we compared the mean apoptosis rate of cumulus cells 
from the three oocytes selected for ICSI with the apoptosis rate of cumulus cells from remaining 
COCs, in order to verify whether COCs morphological selection criteria were related to lower rates 
of apoptosis. 
In the second trial, 4 of the 20 patients were pregnant (20%; A Group) and 16 were not (B 
Group). A total of 12 oocytes from A Group (n = 4) and 48 oocytes from B Group (n = 16) were 
microinjected.  
Particularly, 10 patients out of the 20 involved in this trial had at least 5 MII oocytes and then 
were included in the study. 2 patients of them were pregnant after ICSI cycle (A Group). In most of 
the patients from both groups, the rates of cumulus cells apoptosis were lower among the COCs 
selected for ICSI than in the unselected pooled COCs. 
Specifically, we found a difference in DNA fragmentation rate (18.2 vs 27.1, p<0.05) and in 
Caspase-3 immunoassay (12.9 vs 19.9, p< 0.05)  between A Group and B Group, when it was 
evaluated the differences between the COCs selected by morphological criteria. No differences, 
both in TUNEL assay and in Caspase 3 immunoassay was found in the pooled cells of the 
supernumerary COCs (A group 25.75 vs B Group 29.2 for TUNEL assay; A Group 22.3 vs B 
Group 23.1 for Caspase 3 immunoassay) as shown in Table 4.  
However, pooled cumulus cells from two patients in B Group had a lower rate of apoptosis 
than the pooled cumulus cells from the three selected COCs. In this case, molecular criteria, based 
on the evaluation of apoptosis rate of cumulus cells, would be useful to establish oocyte quality, 
suggesting that COCs morphological criteria, per se, are not entirely representative of good oocyte 
competence. 
 
3. DISCUSSION 
The aim of this study was to identify new markers of quality for human oocyte selection prior 
to ICSI. We hypothesized that low rates of apoptosis in cumulus cells associated with 
morphological COCs selection could be an innovative method for oocyte selection. 
Investigators have previously demonstrated that high rates of cumulus cell apoptosis are 
associated with a poor outcome of assisted reproductive technology (ART) procedures [15, 16]. 
Differently from Lee, et al. [16], our investigation concerns molecular evaluation of apoptosis in 
cumulus cells of individual COCs of the oocytes undergoing ICSI fertilization, previously selected 
by traditional morphological criteria. In our opinion, this is a potential approach that directly 
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correlates the oocyte quality, in terms of reduced rate of cumulus cell apoptosis, to ART outcomes 
expressed as fertilization and pregnancy rates. 
As cumulus cells are fundamental to oocyte maturation [8, 17], it is necessary to use a non-
invasive method to evaluate indirectly the oocyte quality through cumulus cell analysis.  
An increased rate of apoptosis of cumulus cells may affect oocyte maturation and could be a 
marker of poor oocyte quality. Conversely, oocytes play an important role in determining 
functional differences between different granulosa cell lineages and in maintaining anti-apoptotic 
pathways in cumulus cells [18-20]. 
The relationship between apoptosis rates in cumulus cells and the maturity or quality of the 
corresponding oocytes has been studied by other authors. Høst, et al. [21] demonstrated a clear 
correlation between the rates of cumulus cell apoptosis and immature oocytes. In a recent paper [9], 
it was demonstrated that LH administration to specific patients undergoing IVF protocol 
significantly reduced rates of cumulus cell apoptosis, thereby improving clinical outcomes. 
Therefore a significant reduction in the number of immature oocytes collected and a consequent 
increase in the number of embryos to be transferred, as well as an improvement in implantation and 
pregnancy rates. Data from trial 1, where 3 COCs were investigated separately, demonstrated that 
morphological evaluation of COCs is not useful, per se, in selecting the best oocytes with higher 
implantation potentiality. It was concluded that cumulus cells, which maintain their physiological 
function for longer, could provide greater support to the nuclear and cytoplasmic maturation of the 
oocyte until ovulation, thus allowing the collection of oocytes with better ‘intrinsic’ qualities, as is 
necessary for sustaining fertilization and early phases of embryogenesis. However, Moffatt, et al. 
[22], demonstrated that the incidence of cumulus cell apoptosis and the quality oocytes depend on 
patient age and exposure to sperm, but are unrelated to oocyte nuclear maturation. Nonetheless, it is 
agreed that there is an intimate relationship between cumulus cells and their corresponding oocytes. 
Høst, et al. [23] demonstrated that the developmental potential of an oocyte is compromised if the 
related cumulus cells show a high rate of apoptosis; this may also impair the fertilization rate of 
MII oocytes after ICSI and the implantation potential of the derived embryos. This study seems to 
demonstrate that lower apoptosis rate of the cumulus cells, analyzed in individual COC, is a 
stronger and useful marker than traditional morphological criteria. The molecular marker could be 
used in selecting oocytes in older aged patients, in the case of repeated failure cycles and in patients 
with severe endometriosis [24]. 
 
4. CONCLUSION 
Data from the first trial, where the three cumulus oocyte complexes were analyzed separately, 
show that there is a direct relationship between higher apoptosis rate in cumulus cells and 
pregnancy failure. 
The low percentage of apoptosis in cumulus cells in patients who achieved pregnancy also 
shows the importance of the chromatin integrity. 
The evidence from two patients in B Group, who showed a lower rate of apoptosis in pooled 
cumulus cells from non selected oocytes than in the selected ones, reinforces the notion that 
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molecular selection of COCs, based on evaluation of cumulus cells apoptosis, could be more 
sensitive than classical morphological criteria. 
 We have shown that all women in this study who became pregnant had a lower rate of 
cumulus cell apoptosis than those who did not achieve a pregnancy. Our data showed that in most 
pregnant patients, at least 1 of the three oocytes fertilized by ICSI had a lower apoptotic rate of the 
cumulus cells (usually less than 8%), compared with the oocytes of non pregnant ones. Thus, 8% 
cumulus cells apoptotic rate could be considered a cut-off threshold for the oocyte selection. 
In conclusion, we found that evaluation of cumulus cell apoptosis in individual COCs may be a 
selective marker for the best quality oocytes for ICSI.  
 
5. MATERIALS AND METHODS 
5.1. ICSI Procedure and Cumulus Cell Analysis  
Ovarian hyperstimulation was performed using the standard long gonadotrophin-releasing 
hormone agonist (buserelin, 0.2 ml/day) protocol, starting from day 21 of the previous cycle, 
followed by a daily dose of 225 IU of recombinant human follicle-stimulating hormone (r-hFSH; 
GONAL-f
®
; Merck Serono S.p.A., Rome, Italy, an affiliate of Merck KGaA, Darmstadt, Germany). 
Follicular growth and serum oestrogen levels were monitored from the sixth day of stimulation, 
and the dose of r-hFSH was modified accordingly. When at least three or four dominant follicles 
were ≥18 mm in diameter, 10,000 IU of human chorionic gonadotrophin (Gonasi®, AMSA SRL, 
Rome, Italy) was administered.  
A total of 58 COCs from the first trial and 60 COCs from the second trial were selected and 
denudated separately in hyaluronidase (40 IU/ml, SAGE
®
 IVF, Trumbull, CT, USA), 30’ or at least 
2 hours after oocyte collection [25]. 
The cumulus cells were collected in a test tube containing 2 ml of basic culture medium 
(Quinn’s Advantage® Medium with Hepes, SAGE® IVF) and centrifuged twice at 300g for 10 
minutes. The oocytes were transferred to a culture medium (fertilization medium, SAGE
®
 IVF) and 
incubated at 37°C in 5% CO2 until the ICSI procedure. For the ICSI procedure, the semen samples 
were taken 2 hours after oocyte collection, washed in Hepes medium (SAGE
®
 IVF) and centrifuged 
for 7 minutes at 300g. Fertilization medium (50 µl) (SAGE
®
 IVF) was layered on the pellet and the 
sperms were incubated at 37°C in 5% CO2 until ICSI. After 13–16 hours, the oocytes cultured in 
cleavage medium (SAGE
®
 IVF) were checked for the pronuclear presence. After 48 hours, 
embryos were transferred using a catheter. 
 
5.2. Fluorescent in Situ TUNEL Assay (TdT) 
Apoptosis was tested in at least 80 cumulus cells for each of the COCs by TUNEL assay. 
Cumulus cells were fixed in 3.7% paraformaldehyde for 60 minutes. After centrifugation at 300g 
for 5 minutes, the supernatant was removed and phosphate buffer saline (PBS)–glycine buffer was 
added (0.1 M glycine in PBS and 0.3 mg/ml bovine serum albumin [BSA]). The cells were then 
mounted on polylysine-coated glass slides by cytocentrifugation.  
Cumulus cells, mounted on polylysine-coated glass slides, were washed with PBS (137 mM 
NaCl, 2.68 mM KC1, 1.47 mM KH2PO4, 8.1 mM Na2HPO4) and permeated for 10 minutes with 
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0.1% Triton X-100 and 0.1% sodium citrate in PBS at 4°C, and then washed three times in PBS at 
room temperature for 5 minutes. Subsequently, the cell preparations were incubated for 60 minutes 
at 37°C in a humidified chamber in 50 µl of a mixture containing 5 µl nucleotide mix, 1 µl TdT 
enzyme and 45 µl equilibration buffer (Dead-End™ Fluorometric TUNEL System, Promega Italia, 
SRL). 
Cumulus cells were incubated with the same mixture without the TdT enzyme (negative 
control) while another sample was treated for 10 minutes with a DNAse buffer solution containing 
10 unit/ml of DNAse I (positive control). 
The reaction was blocked with saline sodium citrate buffer 2× for 15 minutes, then washed for 
5 minutes with PBS. The cumulus cells were stained with propidium iodide (1 µg/ml) for 10 
minutes at room temperature and observed under an Olympus BX 50 microscope (Olympus, 
Copenhagen, Denmark) equipped with a reflected light fluorescent attachment (Olympus), and a 20 
× 0.40 objective. 
Apoptosis rate: total apoptotic nuclei labelled in green (TUNEL assay)/total nuclei labelled in 
red (Propidium iodide) x 100. 
 
5.3. Immunoassay of Cleaved-Caspase-3  
Apoptosis was tested in at least 80 cumulus cells for each of the COCs by caspase-3 
immunoassay.  
After three washes in PBS, cumulus cells were permeated for 10 minutes at 4°C with 0.1% 
Triton X-100 and 0.1% sodium citrate in PBS. After three rinses with PBS, the cells were 
incubated overnight at 4°C with anti-caspase-3 cleaved polyclonal antibody (Cell Signaling 
Technology
®
) (1:50 dilution) in PBS containing 3% BSA. In negative controls, the primary 
antibody was omitted. After three rinses with PBS, anti-rabbit immunoglobulin fluorescein-linked 
secondary antibody (Amersham) (1:60 dilution in PBS containing 1% BSA) was added to the 
samples for 60 minutes. Then, secondary antibody excess was removed by three washings with 
PBS. Cumulus cells were stained for 10 minutes with propidium iodide (1 µg/ml), mounted in 10 μl 
DABCO solution (de-ionized H2O, 1 M Tris-HCl pH 8, 2 mM DABCO, glycerol) and observed 
under an Olympus BX 50 microscope equipped with a reflected light fluorescent attachment 
(Olympus), and a 40 × 0.55 objective. Apoptosis rate detected by anti-caspase-3 cleaved 
immunoassay was calculated as described for TUNEL assay. 
 
5.4. Statistical Analysis 
Paired Chi and t-tests, were used for the evaluation of differences between groups. Apoptosis 
rates (TUNEL assay and caspase-3 immunoassay) are presented as percentage of cells exhibiting 
fragmented DNA. Differences were considered significant at levels of P < 0.05.  
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Figure-1. Evaluation of apoptosis of a single cumulus cell–oocyte complex 
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a) TUNEL Assay.  
A = A Group; B = B Group; C = Positive control. 
Green: DNA fragmentation (A1, B1, C1). Red: nucleic acids stained with propidium iodide (A2, 
B2, C2). Merge of green and red (A3, B3, C3). Fields observed under fluorescent microscope (20 × 
0.40 objective). Bar = 30µm. 
 
b) Caspase-3 Immunoassay.  
A = A Group; B = B Group. 
Green: immunolocalization of cleaved-caspase-3 (A1, B1). Red: nucleic acids stained with 
propidium iodide (A2, B2). Merge of green and red (A3, B3). Fields observed under fluorescent 
microscope (40 × 0.55 objective).Bar = 30µm. 
 
Table-1. Patient characteristics and COCs collected. 
 Trial 1 Trial 2 
Patients, n 22 20 
Mean (SD) female age, years 34.5 (4.8) 34.8 (3.8) 
Range, years 28–45 31–43 
Mean (SD) male age, years 38.3 (8.3) 38.4 (7.2) 
Range, years 30–56 31–52 
Total number of COCs collected 154 101 
Mean (SD) number 7.0 (3.2) 4.9 (2.2) 
Total number of COCs selected 58 60 
Mean (SD) number 2.9 (0.3) 2.9 (0.3) 
 
COC, cumulus cell–oocyte complex; SD, standard deviation. 
 
Table-2. Oocytes injected, fertilization rates, transferred embryos and clinical outcomes in the two groups studied. 
 
Trial 1 (n = 22) Trial 2 (n = 20) 
A Group B Group A Group B Group 
Injected oocytes, n  24 34 12 48 
Two pronuclear (2PN)-stage oocytes, n 
(%) 
23 (95.8) 29 (85.2) 12 (100) 46 (96) 
Grade A or B embryos transferred, n 23 29 12 46 
Pregnancies, n (%) 
No pregnancies, n (%) 
8 (36.3) 
– 
– 
14 (63.7) 
4 (20.0) 
– 
– 
16 (80.0) 
 
A Group: women that became pregnant; B Group: women that did not become pregnant. Grade A and B according to Bolton’s definition [14]. 
 
Table-3. Apoptosis in cumulus cells analysed by TUNEL assay and caspase-3 immunoassay from Trial 1. 
  A Group n = 8 
B Group n = 
14 
TUNEL assay Apoptosis in cumulus cells, % 6.7 13.2 
 Range 2. 2–13.3 6.2–34.9 
Caspase-3 
immunoassay 
Apoptosis in cumulus cells, % 5.2 11.8 
 Range 1.2–8.6 5.6–14.8 
 
   Differences were considered significant at levels of P < 0.05. 
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Table-4. Apoptosis in cumulus cells analysed by TUNEL assay and caspase-3 immunoassay in selected COCs compared 
with pooled COCs in patients with more than three COCs from Trial 2. 
 
Cumulus cell apoptosis in pooled 
selected COCs
(a) 
 (mean), % 
Cumulus cell apoptosis in pooled 
remaining COCs 
(a) 
(mean), % 
 TUNEL assay 
Caspase-3 
immunoassay 
TUNEL assay 
Caspase-3 
immunoassay 
A Group 
n = 2 
(18.2%) (12.9%) (25.75%) (22.3%) 
Range 17.2–19.2 12.3–13.5 23.1–28.4 20.5–24.1 
B Group 
n = 8 
(27.1%) (19.9%) (29.2%) (23.1%) 
Range 10.0–60.3 7.6–45.3 8.8–67.3 7.2–51.4 
Differences were considered significant at levels of P < 0.05. 
(a) COC: cumulus cell–oocyte complex. 
 
